Treatment of Membranous Nephropathy by Disulfiram through Inhibition of Podocyte Pyroptosis

INTRODUCTION: Membranous nephropathy (MN) is a common chronic kidney disease in adults and a major challenge of clinical practice for its treatment. Despite major advances, since the discovery of the phospholipase A2 receptor as the major autoantigen of podocytes in MN, the mechanisms leading to glo...

Descripción completa

Detalles Bibliográficos
Autores principales: Lv, Daoyuan, Jiang, Song, Zhang, Mingchao, Zhu, Xiaodong, Yang, Fan, Wang, Hui, Li, Shen, Liu, Feng, Zeng, Caihong, Qin, Weisong, Li, Limin, Liu, Zhihong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9386405/
https://www.ncbi.nlm.nih.gov/pubmed/36157258
http://dx.doi.org/10.1159/000524164

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9386405/
https://www.ncbi.nlm.nih.gov/pubmed/36157258
http://dx.doi.org/10.1159/000524164

Ejemplares similares